Millennium Pharmacon International Stock Filter Stocks by Fundamentals
SDPC Stock | IDR 128.00 2.00 1.54% |
Millennium Pharmacon's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Millennium Stock price.
Millennium |
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Millennium Fundamentals
Return On Equity | 0.0938 | |||
Return On Asset | 0.0342 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.02 % | |||
Current Valuation | 828.27 B | |||
Shares Outstanding | 1.27 B | |||
Shares Owned By Insiders | 87.94 % | |||
Shares Owned By Institutions | 3.35 % | |||
Price To Earning | 9.31 X | |||
Price To Book | 1.16 X | |||
Price To Sales | 0.10 X | |||
Revenue | 2.99 T | |||
Gross Profit | 237.04 B | |||
EBITDA | 73.6 B | |||
Net Income | 9.57 B | |||
Cash And Equivalents | 43.62 B | |||
Cash Per Share | 34.24 X | |||
Total Debt | 1.8 B | |||
Debt To Equity | 257.80 % | |||
Current Ratio | 1.15 X | |||
Book Value Per Share | 202.66 X | |||
Cash Flow From Operations | (18.18 B) | |||
Earnings Per Share | 19.19 X | |||
Number Of Employees | 1.09 K | |||
Beta | 0.75 | |||
Market Capitalization | 440.8 B | |||
Total Asset | 1.21 T | |||
Annual Yield | 0 % | |||
Net Asset | 1.21 T | |||
Last Dividend Paid | 1.0 |
About Millennium Pharmacon Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Millennium Pharmacon International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Millennium Pharmacon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Millennium Pharmacon International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Millennium Stock
Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.